12
Sep

Oxygen Biotherapeutics’ rollercoaster development of a brain injury treatment has come to a grinding halt, as the biotech has put an end to a mid-stage trial on the drug and is looking to move on.

…read more

Source: Oxygen Bio halts work on brain injury drug over enrollment woes

    

0 No comments